{"id":10700,"date":"2020-04-14T10:00:25","date_gmt":"2020-04-14T14:00:25","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=10700"},"modified":"2020-10-12T15:10:30","modified_gmt":"2020-10-12T19:10:30","slug":"fda-approves-proventil-generic","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/","title":{"rendered":"FDA approves first generic of Proventil HFA"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first generic version of Proventil HFA (<\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/albuterol-sulfate\"><span style=\"font-weight: 400;\">albuterol sulfate<\/span><\/a><span style=\"font-weight: 400;\">) metered-dose inhaler, 90 mcg\/inhalation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Merck<\/span><span style=\"font-weight: 400;\">, the manufacturer of ProAir, released an authorized generic of ProAir in April 2019, supplied and distributed through one of <\/span><a href=\"https:\/\/investor.endo.com\/news-releases\/news-release-details\/endo-begins-shipment-authorized-generic-version-proventilr\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Endo International\u2019s<\/span><\/a><span style=\"font-weight: 400;\"> operating companies, Par Pharmaceuticals. This new generic version is the first copy of the original formulation, not produced by Merck. Meaning, it\u2019s adding new competition to the market, which should help to decrease price.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What is Proventil generic?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">This particular type of inhaler, sometimes referred to as a rescue inhaler, is intended to be used to prevent or treat bronchospasm in people aged 4 years and older who have reversible obstructive airway disease. It can also be used for the prevention of exercise-induced bronchospasm. <\/span><a href=\"https:\/\/www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Approximately 25 million people<\/span><\/a><span style=\"font-weight: 400;\">, including almost 7 million children, in the United States have asthma, according to the Centers for Disease Control and Prevention (CDC).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">ProAir HFA (albuterol inhaler) and Proventil HFA (albuterol inhaler) are among the most commonly used albuterol sulfate versions of short-acting bronchodilators on the market. Others include <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/ventolin-hfa\"><span style=\"font-weight: 400;\">Ventolin HFA<\/span><\/a><span style=\"font-weight: 400;\"> (albuterol inhaler) and AccuNeb (albuterol nebulizer solution).\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What are the side effects of Proventil HFA generic?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The most common side effects for this type of medication include rhinitis, nausea, vomiting, rapid heart rate, tremor, nervousness, and upper respiratory tract infection, according to the FDA.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">The benefits of Proventil HFA generic<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">This approval comes just a few weeks after the FDA approved another generic albuterol inhaler. The FDA gave approval to Perrigo Pharmaceutical Company to start manufacturing the first generic of <\/span><a href=\"https:\/\/www.singlecare.com\/blog\/news\/proair-hfa-generic-approved\/\"><span style=\"font-weight: 400;\">ProAir HFA<\/span><\/a><span style=\"font-weight: 400;\"> (albuterol sulfate) inhalation aerosol<\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generic-proair-hfa\" target=\"_blank\" rel=\"noopener noreferrer\"> <span style=\"font-weight: 400;\">in late February<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Generally speaking, the release of another generic form of albuterol is good news for people who need this kind of medication, according to allergist J. Allen Meadows, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cIt increases the supply and decreases the cost some, modestly,\u201d Dr. Meadows says.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">A time of increased demand<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">According to FDA Commissioner Stephen M. Hahn, MD, there\u2019s already a growing demand for this type of product.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">\u201cThe FDA recognizes the increased demand for albuterol products during the novel coronavirus pandemic,\u201d Dr. Hahn said in a<\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generic-commonly-used-albuterol-inhaler-treat-and-prevent-bronchospasm\" target=\"_blank\" rel=\"noopener noreferrer\"> <span style=\"font-weight: 400;\">statement<\/span><\/a><span style=\"font-weight: 400;\"> announcing the approval on April 8. \u201cWe remain deeply committed to facilitating access to medical products to help address critical needs of the American public.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Several weeks ago, the ACAAI released a statement acknowledging shortages of albuterol inhalers in certain parts of the country, due in part to an increased use of inhalers for hospitalized patients with <\/span><a href=\"https:\/\/www.singlecare.com\/blog\/news\/coronavirus-covid-19-treatments\/\"><span style=\"font-weight: 400;\">COVID-19 infections<\/span><\/a><span style=\"font-weight: 400;\">. Some hospitals were curtailing the use of nebulizers out of concerns that they could spread the virus through the air.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">But the ACAAI reminded people not to panic and not to worry about stocking up, as one canister of albuterol should last for months. According to Dr. Meadows, one rescue inhaler should last six to 18 months. If you\u2019re using your rescue inhaler up sooner, you may not be <\/span><a href=\"https:\/\/www.singlecare.com\/conditions\/asthma-treatment-and-medications\/\"><span style=\"font-weight: 400;\">controlling your asthma<\/span><\/a><span style=\"font-weight: 400;\"> well enough. In that case, you may need to speak with your healthcare provider about adjusting or changing the prevention medication that you\u2019re taking.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, some people may still worry about shortages of albuterol rescue inhalers, so the news of another albuterol product hitting the market may be reassuring to them, says Dr. Meadows.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cWe should have plenty\u2014don\u2019t worry,\u201d he says.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">When will Proventil generic be available?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">At present, it\u2019s unclear exactly when the new generic will hit the U.S. market. <\/span><a href=\"https:\/\/www.cipla.com\/press-releases-statements\/cipla-receives-final-approval-generic-version-proventilr-hfa-inhalation\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">A statement released by Cipra on April 9<\/span><\/a><span style=\"font-weight: 400;\"> said, \u201cWe are planning shipments in a staggered manner. We are also ensuring that we do our bit by donating the product in this time of need.\u201d<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first generic version of Proventil HFA (albuterol sulfate) metered-dose inhaler, 90 mcg\/inhalation. Merck, the manufacturer of ProAir, released an authorized generic of ProAir in April 2019, supplied and distributed through one of Endo International\u2019s operating companies, Par Pharmaceuticals. This new [&hellip;]<\/p>\n","protected":false},"author":85,"featured_media":6926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4114],"tags":[4141],"coauthors":[9482],"class_list":["post-10700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-fda-approvals","wpautop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA approves first Proventil HFA generic<\/title>\n<meta name=\"description\" content=\"The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first Proventil HFA generic (albuterol sulfate).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves first generic of Proventil HFA\" \/>\n<meta property=\"og:description\" content=\"A new inhaler option will be coming to market for people with asthma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/\" \/>\n<meta property=\"og:site_name\" content=\"The Checkup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/singlecare\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-14T14:00:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-12T19:10:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jennifer Larson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA approves first generic of Proventil HFA\" \/>\n<meta name=\"twitter:description\" content=\"A new inhaler option will be coming to market for people with asthma\" \/>\n<meta name=\"twitter:creator\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:site\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jennifer Larson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/\"},\"author\":{\"name\":\"Janice Rodden\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/169a1d8c8b88282cc3b792a394fc3575\"},\"headline\":\"FDA approves first generic of Proventil HFA\",\"datePublished\":\"2020-04-14T14:00:25+00:00\",\"dateModified\":\"2020-10-12T19:10:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/\"},\"wordCount\":627,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Blog_FDA_Approval_Stamp_Template_Pink2.png\",\"keywords\":[\"FDA approvals\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/\",\"name\":\"FDA approves first Proventil HFA generic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Blog_FDA_Approval_Stamp_Template_Pink2.png\",\"datePublished\":\"2020-04-14T14:00:25+00:00\",\"dateModified\":\"2020-10-12T19:10:30+00:00\",\"description\":\"The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first Proventil HFA generic (albuterol sulfate).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Blog_FDA_Approval_Stamp_Template_Pink2.png\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Blog_FDA_Approval_Stamp_Template_Pink2.png\",\"width\":1920,\"height\":1080,\"caption\":\"A stamp for FDA approval - naloxone OTC\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/fda-approves-proventil-generic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves first generic of Proventil HFA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"name\":\"The Checkup, a health blog by SingleCare\",\"description\":\"Read the latest in prescription, wellness, and healthcare news\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\",\"name\":\"SingleCare\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"width\":1200,\"height\":630,\"caption\":\"SingleCare\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/singlecare\",\"https:\\\/\\\/x.com\\\/SingleCare\",\"https:\\\/\\\/www.instagram.com\\\/singlecare\\\/?hl=en\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/singlecare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCd9kiPIjCQw95-2BHCYePKA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/169a1d8c8b88282cc3b792a394fc3575\",\"name\":\"Janice Rodden\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=gd66250315c656457c96a08c8fc87b6bb\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=g\",\"caption\":\"Janice Rodden\"},\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/author\\\/jrodden\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA approves first Proventil HFA generic","description":"The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first Proventil HFA generic (albuterol sulfate).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves first generic of Proventil HFA","og_description":"A new inhaler option will be coming to market for people with asthma","og_url":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/","og_site_name":"The Checkup","article_publisher":"https:\/\/www.facebook.com\/singlecare","article_published_time":"2020-04-14T14:00:25+00:00","article_modified_time":"2020-10-12T19:10:30+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png","type":"image\/png"}],"author":"Jennifer Larson","twitter_card":"summary_large_image","twitter_title":"FDA approves first generic of Proventil HFA","twitter_description":"A new inhaler option will be coming to market for people with asthma","twitter_creator":"@SingleCare","twitter_site":"@SingleCare","twitter_misc":{"Written by":"Jennifer Larson","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#article","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/"},"author":{"name":"Janice Rodden","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/169a1d8c8b88282cc3b792a394fc3575"},"headline":"FDA approves first generic of Proventil HFA","datePublished":"2020-04-14T14:00:25+00:00","dateModified":"2020-10-12T19:10:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/"},"wordCount":627,"commentCount":0,"publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png","keywords":["FDA approvals"],"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/","url":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/","name":"FDA approves first Proventil HFA generic","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#primaryimage"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png","datePublished":"2020-04-14T14:00:25+00:00","dateModified":"2020-10-12T19:10:30+00:00","description":"The U.S. Food and Drug Administration (FDA) granted approval to Cipla Limited to manufacture the first Proventil HFA generic (albuterol sulfate).","breadcrumb":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#primaryimage","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2019\/11\/Blog_FDA_Approval_Stamp_Template_Pink2.png","width":1920,"height":1080,"caption":"A stamp for FDA approval - naloxone OTC"},{"@type":"BreadcrumbList","@id":"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-proventil-generic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.singlecare.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA approves first generic of Proventil HFA"}]},{"@type":"WebSite","@id":"https:\/\/www.singlecare.com\/blog\/#website","url":"https:\/\/www.singlecare.com\/blog\/","name":"The Checkup, a health blog by SingleCare","description":"Read the latest in prescription, wellness, and healthcare news","publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.singlecare.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.singlecare.com\/blog\/#organization","name":"SingleCare","url":"https:\/\/www.singlecare.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","width":1200,"height":630,"caption":"SingleCare"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/singlecare","https:\/\/x.com\/SingleCare","https:\/\/www.instagram.com\/singlecare\/?hl=en","https:\/\/www.linkedin.com\/company\/singlecare\/","https:\/\/www.youtube.com\/channel\/UCd9kiPIjCQw95-2BHCYePKA"]},{"@type":"Person","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/169a1d8c8b88282cc3b792a394fc3575","name":"Janice Rodden","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=gd66250315c656457c96a08c8fc87b6bb","url":"https:\/\/secure.gravatar.com\/avatar\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/52a9a50886f8a50207b3817add6cf041e73c89f3a5b1776ee5f9642e519a0611?s=96&d=mm&r=g","caption":"Janice Rodden"},"url":"https:\/\/www.singlecare.com\/blog\/author\/jrodden\/"}]}},"_links":{"self":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/10700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/users\/85"}],"replies":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/comments?post=10700"}],"version-history":[{"count":0,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/10700\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media\/6926"}],"wp:attachment":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media?parent=10700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/categories?post=10700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/tags?post=10700"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/coauthors?post=10700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}